SCHEMBL937050

SCHEMBL937050

CC1=CC[C@@H](C(=O)O)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.60
TSHR P16473 2/20 0.44
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRA4 P48169 2/20 0.38
GABRE P78334 2/20 0.38
GABRA6 Q16445 2/20 0.38
GABRG1 Q8N1C3 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1037667 1.00 LMNA (0.60) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL937318 1.00 LMNA (0.60) LMNATSHRALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL4354664 0.98 LMNA (0.58) LMNATSHRALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL937999 0.98 LMNA (0.58) LMNATSHRALDH1A1NPC1RAB9A
Ethylene SCHEMBL27605005 0.96 LMNA (0.61) LMNATSHRALDH1A1NPC1RAB9A
Ethylene Glycol SCHEMBL4324703 0.93 LMNA (0.53) LMNATSHRALDH1A1NPC1RAB9A
Ethylenediamine SCHEMBL3332646 0.91 LMNA (0.51) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL24240093 0.88 LMNA (0.47) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL10774039 0.88 LMNA (0.47) LMNATSHRALDH1A1NPC1RAB9A
Propylene Glycol SCHEMBL4322377 0.87 LMNA (0.47) LMNATSHRALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111464-A1 JAK2 V617F INHIBITORS AND METHODS OF USE THEREOF RAYTHERA, INC. (US) 2025-05-30 WO disclosed
WO-2021046636-A1 CANNABINOID DERIVATIVES, PRECURSORS AND USES KARE CHEMICAL TECHNOLOGIES INC. (CA) 2021-03-18 WO disclosed
EP-3219713-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES Gilead Sciences, Inc. (US) 2017-09-20 EP disclosed
EP-3219713-A1 INHIBITORS OF FLAVIVIRIDAE VIRUSES Gilead Sciences, Inc. (US) 2017-09-20 EP disclosed
WO-2017051355-A1 COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-03-30 WO disclosed
EP-2523950-B1 INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES INC (US) 2017-03-15 EP disclosed
EP-2523950-B1 INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES INC (US) 2017-03-15 EP disclosed
WO-2017017609-A1 BETUIN DERIVATIVES FOR PREVENTING OR TREATING HIV INFECTIONS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-02-02 WO disclosed
US-9321753-B2 Inhibitors of Flaviviridae viruses GILEAD SCIENCES, INC. (US) 2016-04-26 US disclosed
US-9321753-B2 Inhibitors of Flaviviridae viruses GILEAD SCIENCES, INC. (US) 2016-04-26 US disclosed
US-6534434-B2 Catalyst for unsaturated carbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-03-18 US disclosed
US-6515137-B2 Enantioselectivity of alpha,beta-unsaturated aldehydes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-02-04 US disclosed
EP-1263735-A1 ACID ADDITION SALTS OF IMIDAZOLIDINONES AS REACTION CATALYSTS The Regents of The University of California (US) 2002-12-11 EP disclosed
EP-1257519-A1 CHEMICAL TRANSFORMATION OF SUBSTRATES USING NONMETALLIC, ORGANIC CATALYST COMPOSITIONS The Regents of The University of California (US) 2002-11-20 EP disclosed
US-6369243-B1 ACID CATALYST THE REGENTS OF THE UNIVERISITY OF CALIFORNIA 2002-04-09 US disclosed
US-20020016473-A1 Catalytic processes employing chiral imidazolidinone-based catalyst composition MACMILLAN DAVID W C (US) 2002-02-07 US disclosed
US-20020013475-A1 Chiral imidazolidinone-based catalyst composition and reaction system MACMILLAN DAVID W C (US) 2002-01-31 US disclosed
US-6307057-B1 CATALYZE ENANTIOSELECTIVE REACTIONS, E.G., DIELS-ALDER REACTIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-10-23 US disclosed
WO-2001053241-A1 CHEMICAL TRANSFORMATION OF SUBSTRATES USING NONMETALLIC, ORGANIC CATALYST COMPOSITIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-07-26 WO disclosed
WO-2001053269-A1 ACID ADDITION SALTS OF IMIDAZOLIDINONES AS REACTION CATALYSTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013475-A1 Chiral imidazolidinone-based catalyst composition and reaction system COASY, DHPS, INTS9 LMNA 1342/4885TSHR 4061/4885ALDH1A1 78/4885
US-20020016473-A1 Catalytic processes employing chiral imidazolidinone-based catalyst composition COASY, ALDH3A1, TALDO1 LMNA 1202/4885TSHR 4574/4885ALDH1A1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.